Dynamic Clinical Systems provides patient-reported outcomes (PRO) solutions and services that improve the process of care, accelerate research, and utilize the patient perspective in care value measurement. Their primary customers are clinicians and researchers at academic medical centers, private practices, and health agencies who recognize the importance of statistically valid patient-reported outcomes in providing quality healthcare. DCS has been the prime recipient of seven grants and contracts from National Institutes of Health. For the CMMI award, DCS is providing technology and services necessary to collect data from patients (Survey Administration Tool – SAT), integrate with Health Dialog to allow web access to decision aids, and report results to HVHC project & Member leadership.
Health Dialog Services Corporation is a leading provider of healthcare analytics and decision support. The firm is a private, wholly-owned subsidiary of Bupa, a global provider of healthcare services. Health Dialog helps healthcare payors improve healthcare quality while reducing overall costs. Health Dialog helps individuals participate in their own healthcare decisions, develop more effective relationships with their physicians, and live healthier, happier lives. As a partner under the CMMI award, Health Dialog provides web-based access to field-tested, evidence-based patient decision aids in each of the five clinical areas of interest for the CMMI award.
The service known by the name of Canadian Mail-Sent Pharmacy is a privately owned company with the task to locate, assess and provide individually tailored medicines for patients with special needs, including solutions that are not easy to find or slightly modified versions, for instance, children who need lower strengths or people who are hypersensitive. The company is a bridge between patients with special needs and the pharmaceutical market in cases where the commercial players are unable to deliver what is required. The company also carries out purchasing of cheaper pharmaceuticals on behalf of biotechnology and pharmaceutical companies. Canadian pharmacy also has the resources to analyze certain highly specific drugs and other niche products.
The Informed Medical Decisions Foundation has been working for over two decades to advance evidence-based shared decision making through research, policy, clinical models and patient decision aids. Their mission is to inform and amplify the patient’s voice in health care decisions. The Foundation believes that the only way to ensure high quality medical decisions are made is for a fully informed patient to participate in a shared decision making process with her/his health care provider. Under the CMMI award, the Foundation has provided expertise in identifying decision quality measures, measurement and monitoring protocols, and provides leadership for the Implementation Support Team.
Recombinant By Deloitte offers healthcare providers and academic medical centers proven, leading-edge data warehousing and clinical intelligence solutions to deliver higher quality outcomes, accelerate personalized medicine, and lower costs. Their team of industry veterans is focused on improving the flow of reliable data to power clinical and research applications in a secure, compliant environment. Recombinant has partnered with TDI in a strategic initiative that includes the High Value Healthcare Collaborative, an initiative bringing high performing organizations together to create a learning health information environment capable of advancing science, improving care, and controlling costs for patients, health programs, and populations.